首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Interaction Between Deoxyribonucleic Acid and Distamycin A Studied by Transformation in Bacillus subtilis
【2h】

Interaction Between Deoxyribonucleic Acid and Distamycin A Studied by Transformation in Bacillus subtilis

机译:枯草芽孢杆菌转化研究脱氧核糖核酸与地霉素A的相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Distamycin A inhibits deoxyribonucleic acid (DNA)-mediated transformation and transfection in Bacillus subtilis at doses with little or no antibacterial effect. The inhibition of transformation parallels the inhibition of DNA uptake; further-more, during the transformation process, donor DNA molecules become distamycin and deoxyribonuclease resistant at the same time. This demonstrates that the drug acts by inhibiting DNA uptake. Although the drug is known to bind DNA, the inhibition is not related to affinity of the drug for DNA. This is shown by the lack of dependence of the extent of inhibition on DNA concentration, whereas the degree of inhibition depends upon cell concentration. Supporting this view is the fact that transformation by single-stranded DNA was also inhibited, even though the drug does not bind to denatured DNA. Distamycin A probably interferes with transformation by competing with DNA for some unknown bacterial component involved in transport of DNA into the cell.
机译:Distamycin A抑制枯草芽孢杆菌中脱氧核糖核酸(DNA)介导的转化和转染,其剂量几乎没有或没有抗菌作用。转化的抑制与DNA摄取的抑制平行。此外,在转化过程中,供体DNA分子同时变得对双霉素和脱氧核糖核酸酶具有抗性。这表明该药物通过抑制DNA摄取发挥作用。尽管已知该药物可结合DNA,但抑制作用与该药物对DNA的亲和力无关。抑制程度对DNA浓度的依赖性不足表明了这一点,而抑制程度则取决于细胞浓度。支持这种观点的事实是,即使药物不结合变性的DNA,单链DNA的转化也被抑制。 Distamycin A可能通过与DNA竞争涉及DNA转运到细胞中的某些未知细菌成分来干扰转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号